Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|10|3|289-299

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.3, 2012-05, pp. : 289-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

When Cells Become a Drug. Endothelial Progenitor Cells for Cardiovascular Therapy: Aims and Reality

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Endothelial Progenitor Cells for Cardiovascular Diseases

By  

Current Vascular Pharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 59-65

Bentham Science Publishers

Access to resources Recommend Favorite

“Endothelial Progenitor Cells” as a Therapeutic Strategy in Cardiovascular Disease

By  

Current Vascular Pharmacology, Vol. 10, Iss. 1, 2012-01 ,pp. : 107-124

Bentham Science Publishers

Access to resources Recommend Favorite

Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells

By Rupp Stefan  

Basic Research in Cardiology, Vol. 99, Iss. 1, 2004-01 ,pp. : 61-68

Springer Publishing Company

Access to resources Recommend Favorite

Effect of antihypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension

By de Ciuceis Carolina   Pilu Annamaria   Rizzoni Damiano   Porteri Enzo   Muiesan Maria Lorenza   Salvetti Massimo   Paini Anna   Belotti Eugenia   Zani Francesca   Boari Gianluca E. M.   Rosei Claudia Agabiti   Rosei Enrico Agabiti  

Blood Pressure, Vol. 20, Iss. 2, 2011-04 ,pp. : 77-83

Informa Healthcare

Access to resources Recommend Favorite